Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Hooker

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Neuroimage|May 15, 2013
A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference regionMatts Kågedal, Zsolt Cselényi, Svante Nyberg, et al.
BMC Medical Research Methodology|July 30, 2025
Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA scoreNiels Hendrickx, France Mentré, Alzahra Hamdan, et al.
Pharmaceutical Research|February 12, 2025
Correction: Leveraging Model Master Files for Long-Acting InjectablesYuqing Gong, Robert Hopefl, Tonglei Li, et al.
Pharmaceutical Research|January 28, 2025
Leveraging Model Master Files for Long-Acting InjectablesYuqing Gong, Robert Hopefl, Tonglei Li, et al.
The AAPS Journal|February 27, 2024
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDALanyan Fang, Yuqing Gong, Andrew C Hooker, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2018
The Standard Output: A Tool-Agnostic Modeling Storage FormatNadia Terranova, Mike K Smith, Rikard Nordgren, et al.
Orphanet Journal of Rare Diseases|December 20, 2023
Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trialsMartin Geroldinger, Johan Verbeeck, Andrew C Hooker, et al.
Clinical Pharmacology and Therapeutics|November 25, 2020
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model-Based BioequivalenceJieon Lee, Yuqing Gong, Sid Bhoopathy, et al.
Statistics in Medicine|February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional HazardsFlorian Klinglmüller, Tobias Fellinger, Franz König, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2024
A fully automatic tool for development of population pharmacokinetic modelsXiaomei Chen, Rikard Nordgren, Stella Belin, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Neuroimage|May 15, 2013
A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference regionMatts Kågedal, Zsolt Cselényi, Svante Nyberg, et al.
BMC Medical Research Methodology|July 30, 2025
Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA scoreNiels Hendrickx, France Mentré, Alzahra Hamdan, et al.
Pharmaceutical Research|February 12, 2025
Correction: Leveraging Model Master Files for Long-Acting InjectablesYuqing Gong, Robert Hopefl, Tonglei Li, et al.
Pharmaceutical Research|January 28, 2025
Leveraging Model Master Files for Long-Acting InjectablesYuqing Gong, Robert Hopefl, Tonglei Li, et al.
The AAPS Journal|February 27, 2024
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDALanyan Fang, Yuqing Gong, Andrew C Hooker, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2018
The Standard Output: A Tool-Agnostic Modeling Storage FormatNadia Terranova, Mike K Smith, Rikard Nordgren, et al.
Orphanet Journal of Rare Diseases|December 20, 2023
Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trialsMartin Geroldinger, Johan Verbeeck, Andrew C Hooker, et al.
Clinical Pharmacology and Therapeutics|November 25, 2020
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model-Based BioequivalenceJieon Lee, Yuqing Gong, Sid Bhoopathy, et al.
Statistics in Medicine|February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional HazardsFlorian Klinglmüller, Tobias Fellinger, Franz König, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2024
A fully automatic tool for development of population pharmacokinetic modelsXiaomei Chen, Rikard Nordgren, Stella Belin, et al.
Pageof 8